Private equity project
Bio-informatika
Investment in bioinformatics start-up company.
About the project
Through its subsidiary, Science Invest specializes primarily in diagnostic tests, DNA sequencing, bioinformatics analysis, development of new procedures and tests, and development of new software and applications used in bioinformatics.
Diagnostic Tests
In DNA diagnostics, it uses next-generation sequencing technology which enables the identification of pathogenic changes in a short time and within a single analysis. For many tests, a fresh blood sample taken in an EDTA tube is required. Blood sampling is performed by a contractor. Paternity testing based on DNA analysis has become a routine procedure in providing evidence of the relationship between the biological father and the child, and in removing any doubts about the child‘s father or mother in relation to the child‘s paternity. Paternity DNA testing can confirm or rule out a biological relationship with virtually 100% certainty.
Bioinformatics analysis
Development of methods in clinical diagnostics, analysis of variants and viruses, transcriptomic analysis, bio-computer analysis, and custom software development. The company also has extensive experience in the field of biology, statistics, and bioinformatics.
Pharmacogenetic tests
Identification of gene polymorphisms that are part of pharmacokinetic and pharmacodynamic
Fragmentation analysis and DNA sequencing
For the sequence analysis, advisory on setting up and standardizing procedures and protocols enabling the best and longest reading of customer schemes is as important as sequential capillary electrophoresis itself.
Current status
Benefits
-
investícia do slovenskej spoločnosti zameranej na výskum a vývoj a start-up projekty v oblasti bio-informatiky, realizovaná prostredníctvom kúpy 100 % podielu vo firme, ktorá pôsobí v oblasti genetiky už viac ako 10 rokov